This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Valeant Pharmaceuticals International, Inc.
Drug Names(s): griseofulvin ultramicrosize
Description: Gris-PEG is an oral antifungal agent.
Valeant and Pedinol
In April 2012, Valeant acquired Pedinol Pharmacal for less than 1.5 times sales. Revenue for 2011 was approximately $18 million and the transaction was expected to be immediately accretive.
Pink Sheet October Supplemental Approvals
Additional information available to subscribers only: